SMSMED: Revenue and profit declined amid global headwinds, but cash flow and order backlog improved

About this update from Scandinavian Medical Solutions A/s

H1 2025/26 saw revenue and profit decline due to geopolitical uncertainty and market price wars, but cash flow improved and a high order backlog supports a stronger H2. Full-year guidance is maintained, with cost-saving measures and strategic adjustments underway.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Scandinavian Medical Solutions A/s